Bitech Technologies (BTTC) 10-Q 15 May 14 2014 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2014	14-May-14
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'Spine Pain Management, Inc.	'
Document Type	'10-Q	'
Current Fiscal Year End Date	'--12-31	'
Entity Common Stock, Shares Outstanding	'	18,715,882
Amendment Flag	'false	'
Entity Central Index Key	'0001066764	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Well-known Seasoned Issuer	'No	'
Document Period End Date	31-Mar-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'

BALANCE_SHEETS

BALANCE SHEETS (USD $)	Mar. 31, 2014	Dec. 31, 2013
Current assets:	'	'
Cash	$618,551	$687,549
Accounts receivable, net	2,530,316	2,663,652
Prepaid expenses	91,983	116,314
Total current assets	3,240,850	3,467,515
Accounts receivable, net of allowance for doubtful accounts of $362,970 and $352,615 at March 31, 2014 and December 31, 2013, respectively	3,432,505	3,642,864
Intangible assets, net	192,700	197,200
Other assets	19,163	15,770
Total assets	6,885,218	7,323,349
Current liabilities:	'	'
Accounts payable and accrued liabilities	64,400	76,381
Due to related parties	96,431	164,293
Current portion of notes payable and long-term debt, net	500,000	500,000
Total current liabilities	660,831	740,674
Notes payable and long-term debt, net of discount	1,029,902	995,723
Total liabilities	1,690,733	1,736,397
Commitments and contingencies	'	'
Stockholders' equity:	'	'
Common stock: $0.001 par value, 50,000,000 shares authorized, 18,715,882 shares issued and outstanding at March 31, 2014 and December 31, 2013	18,716	18,716
Additional paid-in capital	19,300,489	19,212,669
Accumulated deficit	-14,124,720	-13,644,433
Total stockholders' equity	5,194,485	5,586,952
Total liabilities and stockholders’ equity	$6,885,218	$7,323,349

BALANCE_SHEETS_Parentheticals

BALANCE SHEETS (Parentheticals) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Allowance for doubtful accounts (in Dollars)	$362,970	$352,615
Common stock: par value (in Dollars per share)	$0.00	$0.00
Common stock: shares authorized	50,000,000	50,000,000
Common stock: shares issued	18,715,882	18,715,882
Common stock: shares outstanding	18,715,882	18,715,882

UNAUDITED_CONDENSED_STATEMENTS

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Net revenue	$334,688	$1,043,201
Cost of providing services, including amounts billed by a related party of $44,263 and $171,756 during the three months ended March 31, 2014 and 2013, respectively	145,152	386,761
Gross profit	189,536	656,440
Operating, general and administrative expenses	579,073	490,692
Income (loss) from operations	-389,537	165,748
Other income and (expense):	'	'
Other income	6,748	7,092
Interest expense	-97,498	-126,871
Total other income and (expense)	-90,750	-119,779
Net (loss) income	($480,287)	$45,969
Basic (loss) income per common share (in Dollars per share)	($0.03)	$0
Diluted (loss) income per common share (in Dollars per share)	($0.03)	$0
Shares used in income per common share:	'	'
Basic (in Shares)	18,715,882	18,415,882
Diluted (in Shares)	18,715,882	18,415,882

UNAUDITED_CONDENSED_STATEMENTS1

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS (Parentheticals) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cost of providing services, related party	$44,263	$171,756

UNAUDITED_CONDENSED_STATEMENTS2

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:	'	'
Net income	($480,287)	$45,969
Adjustments to reconcile net income to net cash used in operating activities:	'	'
Bad debt expense	60,000	60,000
Interest expense related to warrant amortization	15,820	42,282
Stock based compensation	127,444	124,500
Accretion of debt discount on long term debt	20,985	28,339
Depreciation and amortization expense	5,900	5,500
Changes in operating assets and liabilities:	'	'
Accounts receivable, net	283,695	-405,945
Prepaid expenses	-17,919	-3,208
Due to related party	-22,862	8,467
Accounts payable and accrued liabilities	-11,981	32,148
Net cash used in operating activities	-19,205	-61,948
Cash flows from investing activities	'	'
Purchase of equipment	-4,793	0
Net cash used in investing activities	-4,793	0
Cash flows from financing activities:	'	'
Repayments on related party notes payable	-45,000	-45,000
Net cash (used in) provided by financing activities	-45,000	-45,000
Net (decrease) increase in cash and cash equivalents	-68,998	-106,948
Cash and cash equivalents at beginning of period	687,549	1,017,755
Cash and cash equivalents at end of period	618,551	910,807
Supplementary disclosure of cash flow information:	'	'
Interest paid	47,500	56,250
Taxes paid	$0	$0

NOTE_1_DESCRIPTION_OF_BUSINESS

NOTE 1. DESCRIPTION OF BUSINESS	3 Months Ended
	Mar. 31, 2014
Disclosure Text Block [Abstract]	'
Nature of Operations [Text Block]	'
	NOTE 1.  DESCRIPTION OF BUSINESS
	Spine Pain Management, Inc. (formerly known as Versa Card, Inc.) was incorporated under the laws of Delaware on March 4, 1998.
	Since inception, we have engaged in and contemplated several ventures and acquisitions, many of which were not consummated.  In December 2008, we began moving forward to launch our new business concept of delivering turnkey solutions to spine surgeons, orthopedic surgeons and other healthcare providers for necessary and appropriate treatment of musculo-skeletal spine injuries.  Our first spine injury diagnostic center opened in Houston, Texas in August 2009.  We currently manage a total of two spine injury diagnostic centers in the United States. We are also evaluating the expansion of our services through additional spine injury diagnostic centers in multiple markets across the country.
	Spine Pain Management, Inc.
	We are a medical services, technology, marketing, management, billing and collection company facilitating diagnostic services for patients who have sustained spine injuries resulting from traumatic accidents.  We deliver turnkey solutions to spine surgeons, orthopedic surgeons and other health care providers for necessary and appropriate treatment of musculo-skeletal spine injuries resulting from automobile and work-related accidents.  Our goal is to become a leader in providing management services to spine and orthopedic surgeons and other healthcare providers to facilitate proper treatment of their injured clients.  By pre-funding the providers accounts receivable, which includes diagnostic testing and non-invasive and surgical care, patients are not unnecessarily delayed or prevented from obtaining needed treatment.  By providing early treatment, we believe that health conditions can be prevented from escalating and injured victims can be quickly placed on the road to recovery.  Through our management system, we facilitate spine surgeons, orthopedic surgeons and other healthcare providers to provide reasonable, necessary, and appropriate treatments to patients with musculo-skeletal spine injuries. We assist the centers that provide the spine diagnostic injections and treatment and pay the doctors a fixed rate for the medical procedures they performed. After a patient is billed for the procedures performed, we take control of the patients’ unpaid bill and oversee collection. In most instances, the patient is a plaintiff in an accident case, where the patient is represented by an attorney. Typically, the defendant (and/or the insurance company of the defendant) in the accident case pays the patient’s bill upon settlement or final judgment of the accident case. The payment to us is made through the attorney of the patient. In most cases, we must agree to the settlement price and the patient must sign off on the settlement. Once we are paid, the patient’s attorney can receive payment for his or her legal fee.
	We currently manage two spine injury diagnostic centers in the United States, which are located in Houston, Texas and San Antonio, Texas. In January 2014 we made the decision to discontinue doing business in Florida and McAllen, Texas (see Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” below).  We are seeking additional funding for expansion by way of reasonable debt financing to accelerate this future development.  In connection with this strategy, we plan to open additional diagnostic centers in new market areas that are attractive under our business model, assuming adequate funds are available.
	We own a device and process by which a video recording system is attached to a fluoroscopic x-ray machine, the “four camera technology,” that we believe can attract additional physicians and patients, expedite settlements and provide us with additional revenue streams.  During 2013 and continuing in 2014, we have refined the technology, through further research and development resulting in a fully commercialized Quad Video Halo System 3.0.  Using this technology, diagnostic procedures are recorded from four separate video feeds that capture views from both inside and outside the body, and a video is made which is given to the plaintiff’s attorney to verify the treatment received.  We believe the video will expedite the settlement process.   Each of our affiliated centers can lease the hardware from us.  Additionally, upon regulatory approval, we anticipate independent medical representatives will sell Quad Video Halo units to outside hospitals and clinics.

NOTE_2_GOING_CONCERN_CONSIDERA

NOTE 2. GOING CONCERN CONSIDERATIONS	3 Months Ended
	Mar. 31, 2014
Going Concern Disclosure [Abstract]	'
Going Concern Disclosure [Text Block]	'NOTE 2.  GOING CONCERN CONSIDERATIONS
	Since our inception in 1998, until commencement of our spine injury diagnostic operations in August, 2009, our expenses substantially exceeded our revenue, resulting in continuing losses and an accumulated deficit from operations of $15,004,698 as of December 31, 2009. Since that time, we have been able to reduce our deficit, and our accumulated deficit is $14,124,720 as of March 31, 2014. During the three months ended March 31, 2014, we realized net revenue of $334,688 and net loss of $480,287. Successful business operations and our transition to positive cash flows from operations are dependent upon obtaining additional financing and achieving a level of collections adequate to support our cost structure. Considering the nature of our business, we are not generating immediate liquidity and sufficient working capital within a reasonable period of time to fund our planned operations and strategic business plan through March 31, 2015. There can be no assurances that there will be adequate financing available to us. The accompanying financial statements have been prepared assuming that we will continue as a going concern. This basis of accounting contemplates the recovery of our assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.

NOTE_3_CRITICAL_ACCOUNTING_POL

NOTE 3. CRITICAL ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Significant Accounting Policies [Text Block]	'
	NOTE 3.  CRITICAL ACCOUNTING POLICIES
	The following are summarized accounting policies considered to be critical by our management:
	Basis of Presentation
	The accompanying unaudited condensed financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC”). Certain information and footnote disclosures, normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such SEC rules and regulations. Nevertheless, we believe that the disclosures are adequate to make the information presented not misleading. These interim condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in our 2013 Annual Report as filed on Form 10-K. In the opinion of management, all adjustments, including normal recurring adjustments necessary to present fairly our financial position with respect to the interim financial statements and the results of its operations for the interim period ended March 31, 2014, have been included. The results of operations for interim periods are not necessarily indicative of the results for a full year.
	Accounting Method
	Our financial statements are prepared using the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of our financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions and could have a material effect on the reported amounts of our financial position and results of operations.
	Revenue Recognition
	Revenues are recognized in accordance with SEC staff accounting bulletin, Topic 13, Revenue Recognition, which specifies that only when persuasive evidence for an arrangement exists; the fee is fixed or determinable; and collection is reasonably assured can revenue be recognized.
	Persuasive evidence of an arrangement is obtained prior to services being rendered when the patient completes and signs the medical and financial paperwork.  Delivery of services is considered to have occurred when medical diagnostic services are provided to the patient.  The price and terms for the services are considered fixed and determinable at the time that the medical services are provided and are based upon the type and extent of the services rendered.  Our credit policy has been established based upon extensive experience by management in the industry and has been determined to ensure that collectability is reasonably assured.  Payment for services are primarily made to us by a third party and the credit policy includes terms of net 240 days for collections; however, collections occur upon settlement or judgment of cases (see Note 4).
	Recent Accounting Pronouncements
	In February 2013, the FASB issued ASU 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income. This new accounting guidance under ASC 220, Comprehensive Income, provides an improvement on the reporting of reclassifications out of accumulated other comprehensive income by requiring an entity to report the effect of significant reclassifications out of accumulated other comprehensive income by component either on the income statement or in the notes to the financial statements. The guidance will become effective prospectively for fiscal years and interim reporting periods beginning after December 15, 2013. Early adoption is permitted.  The adoption of ASU 2013-02 did not have a significant impact on the financial statements.

NOTE_4_ACCOUNTS_RECEIVABLE

NOTE 4. ACCOUNTS RECEIVABLE	3 Months Ended
	Mar. 31, 2014
Receivables [Abstract]	'
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	'
	NOTE 4.  ACCOUNTS RECEIVABLE
	We recognize revenue and accounts receivable in accordance with SEC staff accounting bulletin, Topic 13, “Revenue Recognition”, which requires persuasive evidence that a sales arrangement exists; the fee is fixed or determinable; and collection is reasonably assured before revenue is recognized. We manage certain spine injury diagnostic centers where  healthcare providers perform medical services for patients. We pay the healthcare providers a fixed rate for medical services performed. The patients are billed based on Current Procedural Terminology (“CPT”) codes for the medical procedure performed. CPT codes are numbers assigned to every task and service a medical practitioner may provide to a patient including medical, surgical and diagnostic services. CPT codes are developed, maintained and copyrighted by the American Medical Association. Patients are billed at the normal billing amount, based on national averages, for a particular CPT code procedure. We take control of the patients’ unpaid bills.
	Revenue and corresponding accounts receivable are recognized by reference to “net revenue” and “accounts receivable, net” which is defined as gross amounts billed using CPT codes less account discounts that are expected to result when individual cases are ultimately settled. A discount rate of 52%, based on settled patient cases, was used to reduce revenue to 48% of CPT code billings (“gross revenue”) during the three months ended March 31, 2014 and 2013.
	The patients who receive medical services at the diagnostic centers are typically plaintiffs in accident lawsuits. The timing of collection of receivables is dependent on the timing of a settlement or judgment of each individual case associated with these patients.  Historical experience, through 2013, demonstrated that the collection period for individual cases may extend for two years or more. Accordingly, we have classified receivables as current or long term based on our experience, which indicates that as of March 31, 2014 and 2013 that 40% and 49% of cases will be subject to a settlement or judgment within one year of a medical procedure.
	We take the following steps to establish an arrangement between all parties and facilitate collection upon settlement or final judgment of cases:
		·	The patient completed and signed medical and financial paperwork, which included an acknowledgement of the patient’s responsibility of payment for the services provided. Additionally, the paperwork should include an assignment of benefits derived from any settlement or judgment of the patient’s case.
		·	The patient’s attorney issued the healthcare provider a Letter of Protection designed to guarantee payment for the medical services provided to the patient from proceeds of any settlement or judgment in the accident case. This Letter of Protection also should preclude any case settlement without providing for payment of the patient’s medical bill.
		·	Most of the patients who received medical services at the diagnostic centers have typically been previously referred to a doctor from a plaintiff’s attorney, who performed the initial two to four months of conservative treatment. The doctor then typically refers the patient to one of our healthcare providers for an evaluation because of continuing symptoms. Patients are only accepted if the initial referral was from a reputable plaintiff’s attorney with adequate experience in personal injury lawsuits. Before referring a patient, the attorney is expected to have evaluated the patient’s accident case, including the conditions that gave rise to the patient’s injuries and the extent and quality of general liability insurance held by the defendant. The attorney is also responsible for determining that a settlement favorable to the patient/plaintiff is expected.

NOTE_5_DUE_TO_RELATED_PARTIES

NOTE 5. DUE TO RELATED PARTIES	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	NOTE 5.  DUE TO RELATED PARTIES
	Due to related parties consists of the following:
		March 31,		December 31,
		2014		2013
	Due to Northshore Orthopedics Associates	$	5,732	$	10,406
	Due to Chief Executive Officer		90,699		135,699
	Due to Spine Injury Physicians		-		18,188
		$	96,431	$	164,293
	Amounts due to Northshore Orthopedics, Assoc. (“NSO”, a company owned by our Chief Executive Officer) and our Chief Executive Officer are non-interest bearing, due on demand and do not follow any specific repayment schedule. Amounts due to Spine Injury Physicians (“SIP”, a company owned by our Chief Technology Officer) are non-interest bearing and are due by the 15th of the month following the month in which they were billed. See Note 7 for further information on the amounts due to SIP.

NOTE_6_STOCKHOLDERS_EQUITY

NOTE 6. STOCKHOLDERS' EQUITY	3 Months Ended
	Mar. 31, 2014
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	NOTE 6. STOCKHOLDERS’ EQUITY
	Stock Options
	We recognized $72,000 and $72,000 in compensation expense in operating, general and administrative expenses in the Statements of Operations for the three months ended March 31, 2014 and 2013, respectively. At March 31, 2014, there was approximately $122,110 of total unrecognized compensation expense related to non-vested stock option awards. The remaining $122,110 in compensation expense will be recognized at $72,000 per quarter with the final $122,110 being recognized in the last three quarters ending December 31, 2014.

NOTE_7_RELATED_PARTY_TRANSACTI

NOTE 7. RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	NOTE 7. RELATED PARTY TRANSACTIONS
	Due to Related Parties
	We have an agreement with NSO, which is 100% owned by our Chief Executive Officer, William Donovan, M.D., that provides medical services. As of March 31, 2014 and December 31, 2013, we had balances payable to NSO of $5,732 and $10,406, respectively. This outstanding payable is non-interest bearing, due on demand and does not follow any specific repayment schedule. We do not directly pay Dr. Donovan (in his individual capacity as a physician) any fees in connection with NSO. However, Dr. Donovan is the sole owner of NSO, and we pay NSO under the terms of our agreement.
	As shown in Note 5, at March 31, 2014 and December 31, 2013, we had balances of $90,699 and $135,699, respectively, due to Dr. Donovan, in his individual capacity, for working capital advances and payments made on our behalf. This outstanding payable is non-interest bearing, due on demand and does not follow any specific repayment schedule.
	Also, as shown in Note 5, we had an agreement with SIP, a company 100% owned by Eric Groteke, D.C., who became our Chief Technology Officer on May 9, 2012, to provide medical services as our independent contractor in Florida. SIP is paid for services on a monthly basis dependent upon the services provided.  We discontinued this agreement at the end of 2013.  At March 31, 2014 and December 31, 2013, $0 and $18,188, respectively, was owed to SIP.

NOTE_8_NOTES_PAYABLE

NOTE 8. NOTES PAYABLE	3 Months Ended
	Mar. 31, 2014
Disclosure Text Block [Abstract]	'
Long-term Debt [Text Block]	'
	NOTE 8.  NOTES PAYABLE
	On June 27, 2012, we issued a $500,000 convertible promissory note bearing interest at 12% per year which originally matured on March 27, 2014.  Interest only is due and payable quarterly with the principle balance and unpaid accrued interest due and payable on the maturity date in one lump sum payment.  The holder of the note has the right to convert into common stock, at $1.50 per share, up to 100% of the principal amount.  Under the original terms of the convertible note, the holder received a detachable warrant to purchase 69,445 shares of our common stock at the price of $1.80 per share that expires on June 27, 2014. This note was extended for one year on February 6, 2014 and now matures on March 27, 2015.  As consideration for the extension, we issued an additional 69,445 warrants to purchase our common stock for $0.43 that expire on February 6, 2015.
	The weighted-average estimated fair value of the 69,445 warrants issued, on February 6, 2014 was $0.19 per share using the Black-Sholes pricing model with the following assumptions:
	Expected volatility		110	%
	Risk-free interest rate		0.13	%
	Expected life	1 year
	Dividend yield		0	%

NOTE_9_INCOME_TAXES

NOTE 9. INCOME TAXES	3 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	NOTE 9.  INCOME TAXES
	We have not made provision for income taxes for the three months ended March 31, 2014 or the year ended December 31, 2013, since we have net operating loss carryforwards to offset current taxable income.
	Deferred tax assets consist of the following at March 31, 2014 and December 31, 2013:
		31-Mar			31-Dec
		2014			2013
	Benefit from net operating loss carryforwards	$	2,156,945		$	2,041,083
	Allowance from doubtful accounts		123,409			119,889
	Less:  valuation allowance		(2,280,354	)		(2,160,972	)
		$	-		$	-
	Due to uncertainties surrounding our ability to generate future taxable income to realize these assets, a full valuation has been established to offset the net deferred income tax asset. Based on management’s assessment, utilizing an effective combined tax rate for federal and state taxes of approximately 37%, we have determined that it is not currently likely that a deferred income tax asset of approximately $2,280,354 and $2,160,972 attributable to the future utilization of the approximate $6,343,957 and $6,003,185 in eligible net operating loss carryforwards as of March 31, 2014 and December 31, 2013, respectively, will be realized. We will continue to review this valuation allowance and make adjustments as appropriate. The net operating loss carryforwards will begin to expire in varying amounts from year 2018 to 2031.
	Current income tax laws limit the amount of loss available to be offset against future taxable income when a substantial change in ownership occurs. Therefore, amounts available to offset future taxable income may be limited under Section 382 of the Internal Revenue Code.
	Following is a reconciliation of the (provision) benefit for federal income taxes as reported in the accompanying Statements of Operations to the expected amount at the 34% federal statutory rate:
		Three Months Ended March 31,
		2014			2013
	Income tax benefit (provision) at the 34% statutory rate	$	163,298		$	(15,629	)
	Effect of state income taxes		-			(1,379	)
	Non-deductible interest expense		(41,480	)		(43,680	)
	Other		(2,436	)		38,171
	Less change in valuation allowance		(119,382	)		22,517
	Income tax (provision) benefit	$	-		$	-
	We are subject to taxation in the United States and certain state jurisdictions. Our tax years for 2003 and forward are subject to examination by the United States and applicable state tax authorities due to the carryforwards of unutilized net operating losses and the timing of tax filings.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Basis of Accounting, Policy [Policy Text Block]	'
	Basis of Presentation
	The accompanying unaudited condensed financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC”). Certain information and footnote disclosures, normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such SEC rules and regulations. Nevertheless, we believe that the disclosures are adequate to make the information presented not misleading. These interim condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in our 2013 Annual Report as filed on Form 10-K. In the opinion of management, all adjustments, including normal recurring adjustments necessary to present fairly our financial position with respect to the interim financial statements and the results of its operations for the interim period ended March 31, 2014, have been included. The results of operations for interim periods are not necessarily indicative of the results for a full year.
Accounting Method, Policy [Policy Text Block]	'
	Accounting Method
	Our financial statements are prepared using the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.
Use of Estimates, Policy [Policy Text Block]	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of our financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions and could have a material effect on the reported amounts of our financial position and results of operations.
Revenue Recognition, Policy [Policy Text Block]	'
	Revenue Recognition
	Revenues are recognized in accordance with SEC staff accounting bulletin, Topic 13, Revenue Recognition, which specifies that only when persuasive evidence for an arrangement exists; the fee is fixed or determinable; and collection is reasonably assured can revenue be recognized.
	Persuasive evidence of an arrangement is obtained prior to services being rendered when the patient completes and signs the medical and financial paperwork.  Delivery of services is considered to have occurred when medical diagnostic services are provided to the patient.  The price and terms for the services are considered fixed and determinable at the time that the medical services are provided and are based upon the type and extent of the services rendered.  Our credit policy has been established based upon extensive experience by management in the industry and has been determined to ensure that collectability is reasonably assured.  Payment for services are primarily made to us by a third party and the credit policy includes terms of net 240 days for collections; however, collections occur upon settlement or judgment of cases (see Note 4).
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Recent Accounting Pronouncements
	In February 2013, the FASB issued ASU 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income. This new accounting guidance under ASC 220, Comprehensive Income, provides an improvement on the reporting of reclassifications out of accumulated other comprehensive income by requiring an entity to report the effect of significant reclassifications out of accumulated other comprehensive income by component either on the income statement or in the notes to the financial statements. The guidance will become effective prospectively for fiscal years and interim reporting periods beginning after December 15, 2013. Early adoption is permitted.  The adoption of ASU 2013-02 did not have a significant impact on the financial statements.

NOTE_5_DUE_TO_RELATED_PARTIES_

NOTE 5. DUE TO RELATED PARTIES (Tables)	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Schedule of Related Party Transactions [Table Text Block]	'Due to related parties consists of the following:
		March 31,		December 31,
		2014		2013
	Due to Northshore Orthopedics Associates	$	5,732	$	10,406
	Due to Chief Executive Officer		90,699		135,699
	Due to Spine Injury Physicians		-		18,188
		$	96,431	$	164,293

NOTE_8_NOTES_PAYABLE_Tables

NOTE 8. NOTES PAYABLE (Tables)	3 Months Ended
	Mar. 31, 2014
Disclosure Text Block [Abstract]	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	'The weighted-average estimated fair value of the 69,445 warrants issued, on February 6, 2014 was $0.19 per share using the Black-Sholes pricing model with the following assumptions:
	Expected volatility		110	%
	Risk-free interest rate		0.13	%
	Expected life	1 year
	Dividend yield		0	%

NOTE_9_INCOME_TAXES_Tables

NOTE 9. INCOME TAXES (Tables)	3 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'Deferred tax assets consist of the following at March 31, 2014 and December 31, 2013:
		31-Mar			31-Dec
		2014			2013
	Benefit from net operating loss carryforwards	$	2,156,945		$	2,041,083
	Allowance from doubtful accounts		123,409			119,889
	Less:  valuation allowance		(2,280,354	)		(2,160,972	)
		$	-		$	-
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	'Following is a reconciliation of the (provision) benefit for federal income taxes as reported in the accompanying Statements of Operations to the expected amount at the 34% federal statutory rate:
		Three Months Ended March 31,
		2014			2013
	Income tax benefit (provision) at the 34% statutory rate	$	163,298		$	(15,629	)
	Effect of state income taxes		-			(1,379	)
	Non-deductible interest expense		(41,480	)		(43,680	)
	Other		(2,436	)		38,171
	Less change in valuation allowance		(119,382	)		22,517
	Income tax (provision) benefit	$	-		$	-

NOTE_2_GOING_CONCERN_CONSIDERA1

NOTE 2. GOING CONCERN CONSIDERATIONS (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2009
Going Concern Disclosure [Abstract]	'	'	'	'
Retained Earnings (Accumulated Deficit)	($14,124,720)	'	($13,644,433)	($15,004,698)
Sales Revenue, Services, Net	334,688	1,043,201	'	'
Net Income (Loss) Attributable to Parent	($480,287)	$45,969	'	'

NOTE_3_CRITICAL_ACCOUNTING_POL1

NOTE 3. CRITICAL ACCOUNTING POLICIES (Details)	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Credit policy terms	'240 days

NOTE_4_ACCOUNTS_RECEIVABLE_Det

NOTE 4. ACCOUNTS RECEIVABLE (Details)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
NOTE 4. ACCOUNTS RECEIVABLE (Details) [Line Items]	'	'
Discount rate used for recognition of revenue	52.00%	52.00%
Net revenue recognized as percent of CPT code billings	48.00%	48.00%
Collection period for receivables	'1 year	'1 year
Percentage of cases subject to a settlement within one year	40.00%	49.00%
Minimum [Member]	'	'
NOTE 4. ACCOUNTS RECEIVABLE (Details) [Line Items]	'	'
Collection period for receivables	'2 years	'

NOTE_5_DUE_TO_RELATED_PARTIES_1

NOTE 5. DUE TO RELATED PARTIES (Details) - Schedule of Related Party Transactions (USD $)	Mar. 31, 2014	Dec. 31, 2013
Related Party Transaction [Line Items]	'	'
Due to related parties	$96,431	$164,293
Northshore Orthopedics Associates [Member]	'	'
Related Party Transaction [Line Items]	'	'
Due to related parties	5,732	10,406
Chief Executive Officer [Member]	'	'
Related Party Transaction [Line Items]	'	'
Due to related parties	90,699	135,699
Spine Injury Physicians [Member]	'	'
Related Party Transaction [Line Items]	'	'
Due to related parties	$0	$18,188

NOTE_6_STOCKHOLDERS_EQUITY_Det

NOTE 6. STOCKHOLDERS' EQUITY (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Stockholders' Equity Note [Abstract]	'	'
Allocated Share-based Compensation Expense	$72,000	$72,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	122,110	'
Compensation expense recognized per quarter	72,000	'
Compensation expense recognized in last quarter	$122,110	'
Compensation expense reconized last date	31-Dec-14	'

NOTE_7_RELATED_PARTY_TRANSACTI1

NOTE 7. RELATED PARTY TRANSACTIONS (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
NOTE 7. RELATED PARTY TRANSACTIONS (Details) [Line Items]	'	'
Due to Related Parties, Current	$96,431	$164,293
Northshore Orthopedics Associates [Member]	'	'
NOTE 7. RELATED PARTY TRANSACTIONS (Details) [Line Items]	'	'
Equity Method Investment, Ownership Percentage	100.00%	'
Due to Related Parties, Current	5,732	10,406
Chief Executive Officer [Member]	'	'
NOTE 7. RELATED PARTY TRANSACTIONS (Details) [Line Items]	'	'
Due to Related Parties, Current	90,699	135,699
Spine Injury Physicians [Member]	'	'
NOTE 7. RELATED PARTY TRANSACTIONS (Details) [Line Items]	'	'
Equity Method Investment, Ownership Percentage	100.00%	'
Due to Related Parties, Current	$0	$18,188

NOTE_8_NOTES_PAYABLE_Details

NOTE 8. NOTES PAYABLE (Details) (Convertible Debt [Member], USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2012
Convertible Debt [Member]	'	'
NOTE 8. NOTES PAYABLE (Details) [Line Items]	'	'
Debt Instrument, Issuance Date	'	27-Jun-12
Debt Instrument, Face Amount	'	$500,000
Debt Instrument, Interest Rate, Stated Percentage	'	12.00%
Debt Instrument, Maturity Date	27-Mar-15	27-Mar-14
Debt Instrument, Payment Terms	'Interest only is due and payable quarterly with the principle balance and unpaid accrued interest due and payable on the maturity date in one lump sum payment	'
Debt Instrument, Convertible, Terms of Conversion Feature	'The holder of the note has the right to convert into common stock, at $1.50 per share, up to 100% of the principal amount.	'
Debt Instrument, Convertible, Conversion Price	$1.50	'
Class of Warrant or Rights, Granted	69,445	69,445
Class of Warrant or Right, Exercise Price of Warrants or Rights	$0.43	$1.80
Warrant Expiration Date	6-Feb-15	27-Jun-14
Debt Instrument, Maturity Date, Description	'This note was extended for one year	'
Debt Modification Date	6-Feb-14	'
Warrant Grant Date	6-Feb-14	'
Class of Warrants, Grante in Period, Waighted Average Grant Date Fair Value	$0.19	'

NOTE_8_NOTES_PAYABLE_Details_F

NOTE 8. NOTES PAYABLE (Details) - Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques	3 Months Ended
	Mar. 31, 2014
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Abstract]	'
Expected volatility	110.00%
Risk-free interest rate	0.13%
Expected life	'1 year
Dividend yield	0.00%

NOTE_9_INCOME_TAXES_Details

NOTE 9. INCOME TAXES (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
NOTE 9. INCOME TAXES (Details) [Line Items]	'	'	'
Effective Income Tax Rate Reconciliation, Percent	37.00%	'	'
Deferred Tax Assets, Gross	$2,280,354	'	$2,160,972
Operating Loss Carryforwards	$6,343,957	'	$6,003,185
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	34.00%	34.00%	'
Minimum [Member]	'	'	'
NOTE 9. INCOME TAXES (Details) [Line Items]	'	'	'
Net operating loss carryforwards beginning expiration year	'2018	'	'
Maximum [Member]	'	'	'
NOTE 9. INCOME TAXES (Details) [Line Items]	'	'	'
Net operating loss carryforwards beginning expiration year	'2031	'	'

NOTE_9_INCOME_TAXES_Details_Sc

NOTE 9. INCOME TAXES (Details) - Schedule of Deferred Tax Assets and Liabilities (USD $)	Mar. 31, 2014	Dec. 31, 2013
Schedule of Deferred Tax Assets and Liabilities [Abstract]	'	'
Benefit from net operating loss carryforwards	$2,156,945	$2,041,083
Allowance from doubtful accounts	123,409	119,889
Less: valuation allowance	-2,280,354	-2,160,972
	$0	$0

NOTE_9_INCOME_TAXES_Details_Sc1

NOTE 9. INCOME TAXES (Details) - Schedule of Effective Income Tax Rate Reconciliation (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Schedule of Effective Income Tax Rate Reconciliation [Abstract]	'	'
Income tax benefit (provision) at the 34% statutory rate	$163,298	($15,629)
Effect of state income taxes	0	-1,379
Non-deductible interest expense	-41,480	-43,680
Other	-2,436	38,171
Less change in valuation allowance	-119,382	22,517
Income tax (provision) benefit	$0	$0

NOTE_9_INCOME_TAXES_Details_Sc2

NOTE 9. INCOME TAXES (Details) - Schedule of Effective Income Tax Rate Reconciliation (Parentheticals)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Schedule of Effective Income Tax Rate Reconciliation [Abstract]	'	'
Statutory rate	34.00%	34.00%